Liquid biopsies are a less invasive alternative to traditional tissue biopsies, involving the analysis of biomarkers in bodily fluids like blood. They can detect circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related markers. Liquid biopsies are particularly useful for monitoring disease progression and treatment response in real-time.
